Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron effects on brown adipose tissue in healthy white Caucasian and South Asian men
NL-OMON46185Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of mirabegron in obesity and dyslipidemia (2 cohorts), sponsored by Leiden University Medical Center. Primary endpoint: Brown adipose tissue activity. Started Jun 2016; status: active, not recruiting.
02
Drugs
mirabegron
03
Conditions
obesitydyslipidemia
Beyond the preview
Go deeper on NL-OMON46185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46185.